PPTA 2025 Annual Report

In 2025, PPTA delivered meaningful progress to advance patient access to plasma-derived therapies. Strategic advocacy, collaboration, and data-driven leadership helped strengthen the plasma ecosystem across the United States and Europe.
‍

Read the report for information on:
‍

• Policy and advocacy wins in the U.S. and Europe: PPTA expanded the Congressional Plasma Caucus, advanced tariff exemptions, achieved state-level wins, and elevated recognition of the plasma supply chain in EU policy.
• Science-based regulatory leadership: PPTA strengthened engagement with U.S. and European regulators, modernized guidance, protected operations, and advanced data-driven initiatives like the CORE Study.
• Advancing donor safety and patient access: New donor registries and EU access research supported  stronger donor protections and evidence-based policymaking.
• ‍Global awareness and collaboration: IPAW 2025 united donors,patients, and policymakers worldwide around the lifesaving impact of plasma donation.

‍

Click below to read the full 2025 PPTA Annual Report.